Outlook Therapeutics to Present at the 2020 BIO CEO & Investor Conference
CRANBURY, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop […]